Vimarsana
Biggest News Aggregation in the World

Page 7 - Antipsychotics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antipsychotics Today - Breaking & Trending Today

30+ Experts Question Validity of Serotonin/Depression Study - Vimarsana News

30+ Experts Question Validity of Serotonin/Depression Study

Academics and researchers in psychiatry and psychopharmacology criticize a review that questions the serotonin hypothesis of depression ― a bedrock principle of depression treatment.

Music Therapy Helps Motivate Patients With Schizophrenia - Vimarsana News

Music Therapy Helps Motivate Patients With Schizophrenia

In addition to reducing negative symptoms of schizophrenia, music therapy improves sleep and symptoms of depression.

FDA Approves First Drug to Treat Alzheimer's Agitation - Vimarsana News

FDA Approves First Drug to Treat Alzheimer's Agitation

The antipsychotic brexpiprazole (Rexulti) is the first FDA-approved treatment option for agitation associated with Alzheimer's disease.

Sleep, Circadian Rhythms, Delirium, and the ICU - Vimarsana News

Sleep, Circadian Rhythms, Delirium, and the ICU

Dexmedetomidine is the current darling for improving sleep in patients in the ICU. But does the evidence support it?

Olanzapine Effective for Higher-Risk Chemo-Induced Nausea - Vimarsana News

Olanzapine Effective for Higher-Risk Chemo-Induced Nausea

The antipsychotic improves on standard antiemetic therapy in patients known to be more prone to nausea and vomiting with chemotherapy.